GYRE THERAPEUTICS, INC. Quarterly Operating Lease, Liability in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Gyre Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2019 to Q2 2024.
  • Gyre Therapeutics, Inc. Operating Lease, Liability for the quarter ending June 30, 2024 was $1.96M.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.96M Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $275K Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $409K +$371K +976% Dec 31, 2023 10-K 2024-03-27
Q4 2022 $38K -$2.35M -98.4% Dec 31, 2022 10-K 2023-03-30
Q3 2022 $381K -$2.01M -84.1% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.42M -$1.45M -50.7% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.91M +$425K +28.6% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $2.39M +$741K +45.1% Dec 31, 2021 10-K 2022-03-31
Q3 2021 $2.39M +$950K +65.8% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $2.87M +$1.3M +83.1% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.48M -$202K -12% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $1.64M -$158K -8.77% Dec 31, 2020 10-K 2021-03-04
Q3 2020 $1.44M +$1.44M Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.57M +$1.56M Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $1.69M +$1.68M Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $1.8M Dec 31, 2019 10-K 2020-02-20
Q3 2019 $1.92K* Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $2.03K* Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $2.14K* Mar 31, 2019 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.